Biophysical

MARCH 2007

In This Issue

Biomarkers at Work: Biophysical250 helps Physician Uncover his Own Celiac Disease

Biomarker Research: Biomarker Research Contributes to Diagnosis of Celiac Disease

Partner Profile: Canyon Ranch Offers Biophysical250

What's New: Callum G. Fraser joins Biophysical Advisory Board

In the News: The Wall Street Journal.

Did You Know?

Biomarkers at Work

Biophysical250 helps physician uncover his own celiac disease.

Walter Gaman, M.D., simply attributed his fatigue to the pressure of working 10-hour days juggling the demands of two medical practices. He blamed his intestinal problems on eating a lot of fiber and his tooth enamel loss on having rickets as a small child. He never suspected he had celiac disease. Like many people who have the disease, Dr. Gaman explained away the symptoms of celiac disease–the inability to tolerate a protein called gluten–to other causes. It wasn't until he took the Biophysical250, that it all began to add up. READ MORE

Biomarker Research

Biomarker research contributes to diagnosis of celiac disease.

Several recent medical journal articles have been written on celiac disease as new blood screening techniques have led to discovery of undiagnosed cases, giving rise to a growing known prevalence in worldwide populations. One of the most informative articles is Advances in celiac disease, published in Gastroenterology Clinics (Volume 32, Number 3, September 2003). In this article, Raanan Shamir, M.D., presents the symptoms and advancements in the diagnosis of celiac disease, including the role biomarkers play, as well as the treatment and prevention of the disease in children and adults.

Partner Profile

Canyon Ranch

Canyon Ranch offers Biophysical250.

Recognized as the foremost wellness lifestyle company in the world, Canyon Ranch sets the standard for all other health resorts. Founded 27 years ago by health and wellness icons Mel and Enid Zuckerman, the life-enhancement company today operates two destination health resorts located in Tucson, Arizona and Lenox, Massachusetts, and three Canyon Ranch SpaClub® fitness, spa and wellness facilities. In 2007, the first Canyon Ranch Living residential community, a private beachfront condominium residence, will open in Miami Beach, with another community underway in Chicago. Among its accolades and awards from top travel and lifestyle magazines, Canyon Ranch has been named a Conde Nast Traveler "Best Spa" 10 times since 1990 as well as winning its coveted "Spa of the Decade Hall of Fame Award". READ MORE

What's New

Biophysical welcomes new Medical Advisory Board member.

Callum G. Fraser

We are pleased to announce that Callum G. Fraser, BSc, PhD, FAACB, has joined the Biophysical Scientific Advisory Board. Professor Fraser is a world-renowned clinical biochemist, research scientist, lecturer and author, specializing in the study of individual biological variation data to set quality specifications in laboratory medicine using biomarkers. He has served on many national and international professional bodies, including acting chairman of the Education Committee of the International Federation of Clinical Chemistry and for the World Health Organization. He is currently Consultant Clinical Biochemist in Biochemical Medicine and Honorary Professor at the University of Dundee in Scotland. Professor Fraser will be collaborating with Biophysical on setting reference values for newly discovered biomarkers. To read more about Professor Fraser please visit www.biophysicalcorp.com/advisoryboard

 

Walter Gaman

When I learned about Biophysical250, I knew it would be a wonderful screening tool for my patients,” said Dr. Gaman. “I never expected that my own results would come back anything but completely normal.”

Walter Gaman, M.D.
Co-Partner
Executive Medicine of Southlake

In The News

The Wall Street Journal

"Federal agencies, cancer centers and biotech companies are making big bets on biomarkers, with the National Cancer Institute spending $135 million to identify new cancer biomarkers, and medical labs such as Roche Diagnostics, a division of the Basel, Switzerland-based drug giant, investing millions more."

Sharon Begley
Science Journal Columnist
The Wall Street Journal.

Biophysical was featured in “The Rush to Biomarker Tests” in the December 12, 2006 issue of The Wall Street Journal. WSJ Science Journal Columnist Sharon Begley gives her take on the rising popularity of biomarker testing for the detection of early-stage disease. READ MORE

Did You Know...

...that the FDA issued a proposal on January 22nd to set voluntary standards for food manufacturers to label foods “gluten-free” to help people with celiac disease avoid gluten in packaged foods.